Impaired Renal Function May Not Negate the Efficacy of Tolvaptan in the Treatment of Cirrhotic Patients with Refractory Ascites
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Drug Investigation"
DOI: 10.1007/s40261-018-0714-5
Abstract: Background and ObjectiveTolvaptan, an oral vasopressin V2 receptor antagonist, has been widely used for the treatment of patients with cirrhosis and ascites. However, its efficacy in patients with renal dysfunction remains unknown. The objective of… read more here.
Keywords: treatment; group; ckd ckd; ckd group ... See more keywords
Does Chronic Kidney Disease Really Affect the Complications and Prognosis After Liver Resection for Hepatocellular Carcinoma? A Meta-Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Surgery"
DOI: 10.3389/fsurg.2022.870946
Abstract: Purpose The purpose of this meta-analysis was to analyze whether chronic kidney disease (CKD) affected the complications and prognosis after liver resection for hepatocellular carcinoma. Methods The PubMed, Embase, and Cochrane Library databases were searched… read more here.
Keywords: meta analysis; ckd group; disease;
Use of Levetiracetam in Epileptic Dogs with Chronic Kidney Disease: A Retrospective Study
Sign Up to like & getrecommendations! Published in 2021 at "Veterinary Sciences"
DOI: 10.3390/vetsci8110263
Abstract: In human medicine, doses of levetiracetam (LEV) are individualized for patients with epilepsy, depending on the status of the patient’s renal function. However, there are not reports on the individualized dosing of LEV for small… read more here.
Keywords: chronic kidney; group; ckd group; dogs chronic ... See more keywords